Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Establishment of a Plasmid-Based Reverse Genetics System for the Cell Culture-Adapted Hepatitis E Virus Genotype 3c Strain 47832c.

Scholz J, Bächlein C, Gadicherla AK, Falkenhagen A, Tausch SH, Johne R.

Pathogens. 2020 Feb 25;9(3). pii: E157. doi: 10.3390/pathogens9030157.

2.

Mitoferrin-1 is required for brain energy metabolism and hippocampus-dependent memory.

Baldauf L, Endres T, Scholz J, Kirches E, Ward DM, Lessmann V, Borucki K, Mawrin C.

Neurosci Lett. 2019 Nov 20;713:134521. doi: 10.1016/j.neulet.2019.134521. Epub 2019 Sep 26.

PMID:
31563673
3.

Bone and soft tissue palatal morphology and potential anchorage sides in cleft palate patients.

Moscarino S, Scholz J, Bastian A, Knaup I, Wolf M.

Ann Anat. 2019 Jul;224:41-46. doi: 10.1016/j.aanat.2019.02.005. Epub 2019 Apr 3.

PMID:
30953811
4.

Digital Technologies for Forest Supply Chain Optimization: Existing Solutions and Future Trends.

Scholz J, De Meyer A, Marques AS, Pinho TM, Boaventura-Cunha J, Van Orshoven J, Rosset C, Künzi J, Kaarle J, Nummila K.

Environ Manage. 2018 Dec;62(6):1108-1133. doi: 10.1007/s00267-018-1095-5. Epub 2018 Aug 20. Review.

PMID:
30128584
5.

Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.

Yesilöz Ü, Kirches E, Hartmann C, Scholz J, Kropf S, Sahm F, Nakamura M, Mawrin C.

Neuro Oncol. 2017 Aug 1;19(8):1088-1096. doi: 10.1093/neuonc/nox018.

6.

Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells.

Tuchen M, Wilisch-Neumann A, Daniel EA, Baldauf L, Pachow D, Scholz J, Angenstein F, Stork O, Kirches E, Mawrin C.

Eur J Cancer. 2017 Mar;73:9-21. doi: 10.1016/j.ejca.2016.12.004. Epub 2017 Jan 9.

PMID:
28082204
7.

Benefits of intraoperative digital subtraction angiography in primary arteriovenous fistula creation.

Förster R, Scholz J.

J Vasc Access. 2009 Jul-Sep;10(3):167-73.

PMID:
19670169

Supplemental Content

Loading ...
Support Center